Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
OK Biotech Co., Ltd. (4155.TW)
TWD16.15
+0.55 (+3.53%)
TW TAI Healthcare Medical - Devices
Address
No. 91, Gongdao 5th Road 30070
Hsinchu City, TW
Hsinchu City, TW
CEO
Jia-De Lai
Website
okbiotech.com
IPO
2012-06-20
ISIN TW0004155007
Description
OK Biotech Co., Ltd., established in 2006 and based in Hsinchu City, Taiwan, is a global producer and vendor of blood glucose meters. Its product line further encompasses nebulizers, glucometers, blood sugar meters, blood glucose test strips, and personal sound amplifiers.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
TWD16.15
+0.55 (+3.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
442.6K
Beta
0.26
Float Shares
126.92M
Free Float %
87.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.65% | +5.92% | +16.03% | +6.29% | +2.70% | +4.83% | -13.88% | -49.55% | -21.81% | -37.45% | -16.89% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
16.15
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.79
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-6.8% Q1'26: -6.9% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-10.9% Q1'26: +129.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+14.5% Q1'26: +1.2% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+6.9% ★ Q1'26: +15.7% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+3.1% Q1'26: +6.2% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+14.4% Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×5.13× Q1'26: 3.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
Dec 2032 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
856.55M
est: 1.03B (-16.8%)
|
1.04B
est: 1.03B (+1.0%)
|
1.23B
est: 1.27B (-3.1%)
|
1.12B
est: 1.29B (-13.4%)
|
1.24B
est: 1.26B (-1.3%)
|
1.48B
est: 1.45B (+2.1%)
|
1.26B
est: 1.50B (-15.7%)
|
1.48B
est: 1.57B (-5.5%)
|
1.19B
est: 1.86B (-35.9%)
|
1.67B
est: 1.86B (-10.2%)
|
1.27B
1.27B – 1.27B
-31.6% YoY
|
1.29B
1.29B – 1.29B
+1.7% YoY
|
1.26B
1.26B – 1.26B
-2.8% YoY
|
1.45B
1.45B – 1.45B
+15.6% YoY
|
1.50B
1.50B – 1.50B
+3.0% YoY
|
1.57B
1.57B – 1.57B
+4.8% YoY
|
1.86B
1.86B – 1.86B
+18.5% YoY
|
| EBITDA |
153.91M
est: 112.52M (+36.8%)
|
133.89M
est: 112.52M (+19.0%)
|
145.73M
est: 138.96M (+4.9%)
|
201.70M
est: 141.36M (+42.7%)
|
164.35M
est: 137.37M (+19.6%)
|
171.24M
est: 158.84M (+7.8%)
|
85.45M
est: 163.64M (-47.8%)
|
247.47M
est: 171.51M (+44.3%)
|
87.24M
est: 203.19M (-57.1%)
|
205.76M
est: 208.44M (-1.3%)
|
142.55M
142.55M – 142.55M
-31.6% YoY
|
145.01M
145.01M – 145.01M
+1.7% YoY
|
140.92M
140.92M – 140.92M
-2.8% YoY
|
162.94M
162.94M – 162.94M
+15.6% YoY
|
167.88M
167.88M – 167.88M
+3.0% YoY
|
175.94M
175.94M – 175.94M
+4.8% YoY
|
208.44M
208.44M – 208.44M
+18.5% YoY
|
| EBIT |
150.34M
est: 65.04M (+131.1%)
|
136.16M
est: 65.04M (+109.3%)
|
167.22M
est: 80.32M (+108.2%)
|
206.90M
est: 81.71M (+153.2%)
|
122.79M
est: 79.41M (+54.6%)
|
159.78M
est: 91.82M (+74.0%)
|
54.22M
est: 94.60M (-42.7%)
|
187.02M
est: 99.14M (+88.6%)
|
11.70M
est: 117.46M (-90.0%)
|
133.34M
est: 112.88M (+18.1%)
|
77.20M
77.20M – 77.20M
-31.6% YoY
|
78.53M
78.53M – 78.53M
+1.7% YoY
|
76.32M
76.32M – 76.32M
-2.8% YoY
|
88.24M
88.24M – 88.24M
+15.6% YoY
|
90.91M
90.91M – 90.91M
+3.0% YoY
|
95.28M
95.28M – 95.28M
+4.8% YoY
|
112.88M
112.88M – 112.88M
+18.5% YoY
|
| Net Income |
110.97M
est: 275.38M (-59.7%)
|
85.20M
est: 275.38M (-69.1%)
|
126.81M
est: 206.79M (-38.7%)
|
161.36M
est: 204.33M (-21.0%)
|
125.76M
est: 215.53M (-41.7%)
|
129.73M
est: 324.57M (-60.0%)
|
31.42M
est: 194.74M (-83.9%)
|
143.46M
est: 253.17M (-43.3%)
|
2.95M
est: 308.99M (-99.0%)
|
93.98M
est: 353.43M (-73.4%)
|
236.53M
236.53M – 236.53M
-33.1% YoY
|
233.72M
233.72M – 233.72M
-1.2% YoY
|
246.53M
246.53M – 246.53M
+5.5% YoY
|
371.25M
371.25M – 371.25M
+50.6% YoY
|
222.75M
222.75M – 222.75M
-40.0% YoY
|
289.58M
289.58M – 289.58M
+30.0% YoY
|
353.43M
353.43M – 353.43M
+22.1% YoY
|
| SGA |
148.21M
est: 114.47M (+29.5%)
|
88.32M
est: 114.47M (-22.8%)
|
118.14M
est: 141.37M (-16.4%)
|
127.24M
est: 143.81M (-11.5%)
|
156.53M
est: 139.75M (+12.0%)
|
152.14M
est: 161.59M (-5.8%)
|
148.24M
est: 166.48M (-11.0%)
|
156.09M
est: 174.49M (-10.5%)
|
148.41M
est: 206.72M (-28.2%)
|
177.25M
est: 228.60M (-22.5%)
|
156.33M
156.33M – 156.33M
-31.6% YoY
|
159.04M
159.04M – 159.04M
+1.7% YoY
|
154.55M
154.55M – 154.55M
-2.8% YoY
|
178.70M
178.70M – 178.70M
+15.6% YoY
|
184.11M
184.11M – 184.11M
+3.0% YoY
|
192.96M
192.96M – 192.96M
+4.8% YoY
|
228.60M
228.60M – 228.60M
+18.5% YoY
|
| EPS |
1.68
est: 1.88 (-10.7%)
|
1.29
est: 1.88 (-31.4%)
|
1.88
est: 1.41 (+33.1%)
|
2.04
est: 1.40 (+46.2%)
|
1.49
est: 1.47 (+1.2%)
|
1.39
est: 2.22 (-37.3%)
|
0.30
est: 1.33 (-77.4%)
|
1.34
est: 1.73 (-22.5%)
|
0.02
est: 2.11 (-98.9%)
|
0.66
est: 2.11 (-68.7%)
|
1.41
1.41 – 1.41
-33.1% YoY
|
1.40
1.40 – 1.40
-1.2% YoY
|
1.47
1.47 – 1.47
+5.5% YoY
|
2.22
2.22 – 2.22
+50.6% YoY
|
1.33
1.33 – 1.33
-40.0% YoY
|
1.73
1.73 – 1.73
+30.0% YoY
|
2.11
2.11 – 2.11
+22.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-166.20M
OE per share TTM
-1.22
Owner's Yield
-7.75%
Maintenance CapEx ratio
289.38%
Maint CapEx / Avg PPE
73.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 3 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 45.2K | 0.39% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.00% | 486.17 | 0.42% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 27.6K | 0.28% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.74M
Shares Outstanding
144.81M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chia-De Lai | General Manager, MD & Chairman of the Board | — | male |
| De Quan Zhang | COO & Deputy GM | — | — |
| De Zhao Wang | Business Office Associate, Director | — | — |
| Jia De Lai | General Manager, MD & Chairman of the Board | — | male |
| Qi Zheng Hou | CFO, Financial Manager & Accounting Supervisor | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4155.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
